Navigation Links
Lung Cancer Alliance Commends Leadership of MA State Senate
Date:3/13/2008

First-ever State Funded Lung Cancer Research Bill Given Hearing in Joint Committee on Revenue

WASHINGTON, March 13 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance praised the efforts of State Senator Susan Fargo for helping shepherd first-ever lung cancer research funding bill through the Massachusetts State Senate Committee on Revenue. Senate Bill #2454 would establish a "trust fund," known as the Commonwealth Lung Cancer Early Detection and Treatment Research Fund, which would be funded by a percentage of the cigarette tax and would support research grants for early detection and treatment.

"Lung cancer is the leading cause of cancer death among men and women nationally and in Massachusetts," said Senator Fargo. "This year alone 3,360 Massachusetts residents will succumb to this disease. This is unacceptable, and it is time that we addressed this public health epidemic with the compassion and support it rightly deserves. I am confident that Massachusetts can and will lead the way."

Dozens filled the committee room to testify or submitted letters in support of the legislation. "No one deserves lung cancer," said Diane Legg, a survivor and State Co-Chairwoman of Lung Cancer Alliance - Massachusetts (LCA-MA). "This is one of the most exciting days for me since my lung cancer diagnosis. Fortunately my lung cancer was caught early -- which is why helping others at risk detect and treat their lung cancer earlier is absolutely critical. Thank you, Senator Fargo for your leadership on this issue."

Lung cancer claims more lives each year than breast, prostate, colon, liver, kidney and melanoma cancers combined. Over 70% of those diagnosed with lung cancer are diagnosed at late stage which accounts for its low five-year survival rate of 15%. In addition, 60% of those now diagnosed quit smoking decades ago or never smoked at all.

"It makes no difference whether you smoked or not," said Joanne O'Connor, who lost her sister to lung cancer and is LCA-MA State Co-Chairwoman. "What matters is that lung cancer is a disease and no longer should be ignored or stigmatized. Too many are dying needlessly because of the lack of more robust early detection and treatment programs."

The Joint Committee on Revenue will have until March 19th to act on the bill. The bill will proceed to the Ways and Means Committee if ruled upon favorably. LCA-MA will continue to collaborate with all other public health leaders, including the American Lung Association of New England, to advance this ground breaking legislation.

Lung Cancer Alliance (http://www.LungCancerAlliance.org) is the only national non-profit organization dedicated exclusively to patient support and advocacy for those living with or at risk for lung cancer. Lung Cancer Alliance is committed to leading the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Panel Supports Anemia Drugs for Cancer Patients
2. Womens Risk for a Certain Skin Cancer Varies by Geography
3. Is increased Slug expression associated with the progression to esophageal cancer?
4. Routinely used diagnostic approaches: only limited diagnostic sensitivity for bile duct cancer?
5. American Cancer Society science reporters briefing to feature latest developments in cancer
6. FDA Panel Weighs Safety of Anemia Drugs for Cancer Patients
7. Cancer Survivors Lobby Lifetime TV to Order More of Side Order of Life
8. DNA detectives find genetic markers for lung cancers most likely to recur
9. Researchers find cause of severe allergic reaction to cancer drug
10. Doctors See How Cancer Drug Can Damage Kidneys
11. Genetic Markers May Predict Lung Cancer Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... 05, 2016 , ... Qrono Inc. , a specialty ... collaboration with the Australian critical medicine company, Phebra Pty Ltd. , to ... medicines can offer improved therapeutic benefits over oral formulations, including better bioavailability, improved ...
(Date:5/5/2016)... ... , ... Einstein Medical is proud to announce that it has ... commentary at the 2016 ASCRS/ASOA Symposium and Congress, which takes place in New Orleans, ... Refractive Surgery and the American Society of Ophthalmic Administrations will be held at the ...
(Date:5/5/2016)... Francisco, CA (PRWEB) , ... May 05, 2016 , ... This weekend, from Friday, May ... will take on steep California terrain at the first Team Semper Fi Mountain Bike Camp, ... Joining them will be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Business Journalists , led by the Wharton School’s most prominent professors, help ... one-day program at the Wharton School’s San Francisco campus will feature Wharton ...
(Date:5/5/2016)... ... May 05, 2016 , ... Derrin Doty Group has ... of Bremerton, Port Orchard and communities west of Seattle. The insurance provider’s caring team ... local girl who died suddenly due to complications from the flu, that they have ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology: